SCA
GHDX

SAC Capital Advisors’s Genomic Health, Inc. GHDX Stock Holding History

SAC Capital Advisors’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-14,221
Closed -$416K – 2071
2013
Q4 		$416K Buy
+14,221
New +$451K ﹤0.01% 1256

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
ICM
IronBridge Capital Management Oakbrook Terrace, Illinois $1.65B AUM 18.98% 1-Year Est. Return

SAC Capital Advisors's GHDX Position: Q1 2014 in Review

SAC Capital Advisors sold out of Genomic Health, Inc. (GHDX) in Q1 2014, closing a stake of 14,221 shares — an estimated $416K sold.

SAC Capital Advisors first reported a position in GHDX in Q4 2013 and held it in 1 quarter. The position peaked at $416K in Q4 2013. 101 funds tracked by Wall St. Rank hold GHDX as of Q1 2014.

  • SAC Capital Advisors reported no remaining Genomic Health, Inc. position as of Q1 2014 after selling out during the quarter.
  • SAC Capital Advisors sold 14,221 Genomic Health, Inc. shares in Q1 2014, an estimated $416K.
  • SAC Capital Advisors first reported a position in Genomic Health, Inc. in Q4 2013 and held it in 1 quarter.
  • SAC Capital Advisors's Genomic Health, Inc. position peaked at $416K in Q4 2013.
  • 101 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q1 2014.

Based on SAC Capital Advisors's 13F filing for Q1 2014, filed 15 May 2014.